The future: aligning regulatory and health technology assessments outcomes
This article was originally published in SRA
Executive Summary
The aims of the different stakeholders are too diverse for there to be true convergence of regulatory and HTA outcomes in the pharmaceutical arena. But much can still be done to improve on the current situation, says Johan Strömquist.